Granisetron Patent Expiration
Granisetron is Used for preventing and treating nausea and vomiting associated with chemotherapy and other conditions. It was first introduced by Cumberland Pharmaceuticals Inc
Granisetron Patents
Given below is the list of patents protecting Granisetron, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sancuso | US7608282 | Transdermal granisetron |
Jan 22, 2025
(Expired) | Cumberland |
| Sustol | US10357570 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron |
Sep 28, 2024
(Expired) | Heron Theraps Inc |
| Sustol | US8252304 | Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron |
Sep 28, 2024
(Expired) | Heron Theraps Inc |
| Sustol | US8252305 | Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetron |
Sep 28, 2024
(Expired) | Heron Theraps Inc |
| Sustol | US8715710 | Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron |
Sep 28, 2024
(Expired) | Heron Theraps Inc |
| Sustol | US9913910 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron |
Sep 28, 2024
(Expired) | Heron Theraps Inc |
| Sustol | US6613355 | Semi-solid delivery vehicle and pharmaceutical compositions |
Jun 28, 2021
(Expired) | Heron Theraps Inc |
| Sustol | US6790458 | Pharmaceutical compositions using semi-solid delivery vehicle |
May 11, 2021
(Expired) | Heron Theraps Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Granisetron's patents.
Latest Legal Activities on Granisetron's Patents
Given below is the list recent legal activities going on the following patents of Granisetron.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 28 Feb, 2024 | US8252304 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 28 Feb, 2024 | US8252305 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Jan, 2023 | US10357570 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 13 Sep, 2021 | US9913910 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Apr, 2021 | US7608282(Litigated) |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 28 Feb, 2020 | US8252305 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 28 Feb, 2020 | US8252304 |
| Patent Issue Date Used in PTA Calculation Critical | 23 Jul, 2019 | US10357570 |
| Recordation of Patent Grant Mailed Critical | 23 Jul, 2019 | US10357570 |
| Email Notification Critical | 03 Jul, 2019 | US10357570 |
Granisetron's Family Patents
